Form D · Other Technology

Visana Health, Inc.

Minneapolis, MN · CIK 0001783845

Offering snapshot reported Apr 27, 2026 · SEC filing

Reported sold
$20.3K
Offering amount: $20.3K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 10, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 27, 2026Initial$20,300No comparison1SEC filing
Aug 18, 2025Initial$23,677,424No comparison10SEC filing
Nov 4, 2024Initial$6,000,000No comparison7SEC filing
Jun 30, 2023Initial$125,000No comparison3SEC filing
Jun 9, 2023Initial$13,364,856No comparison18SEC filing
Apr 20, 2022Amendment$2,350,000$1,650,000vs Feb 17, 20229SEC filing
Feb 17, 2022Initial$700,000No comparison3SEC filing
Aug 5, 2019Initial$130,000No comparison2SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-581896
The Total Offering Amount and Total Amount Sold represent the aggregate exercise price of certain warrants to purchase shares of capital stock of the Issuer

Source: Form D, filed Apr 27, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Olivia Capra Director
Joseph M. Connolly Director, Executive
Scib Ebel Executive
Carla Eckhardt Taracena Executive
Shelly Lanning Director, Executive
Barbara Levy Executive
Margaret Malone Director
Tom Maraday Executive
Spence Mc Clelland Director
Conrad Pendergast Executive
Chevon Rariy Executive
Michael N. Tudeen Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
5123 West 98 Th Street #1345
Minneapolis, MN, 55437